Marco Foppoli

1.9k total citations
30 papers, 738 citations indexed

About

Marco Foppoli is a scholar working on Pathology and Forensic Medicine, Neurology and Genetics. According to data from OpenAlex, Marco Foppoli has authored 30 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 17 papers in Neurology and 12 papers in Genetics. Recurrent topics in Marco Foppoli's work include Lymphoma Diagnosis and Treatment (20 papers), CNS Lymphoma Diagnosis and Treatment (17 papers) and Glioma Diagnosis and Treatment (8 papers). Marco Foppoli is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), CNS Lymphoma Diagnosis and Treatment (17 papers) and Glioma Diagnosis and Treatment (8 papers). Marco Foppoli collaborates with scholars based in Italy, Switzerland and Greece. Marco Foppoli's co-authors include Andrés J.M. Ferreri, Giovanni Citterio, Michele Reni, Maurilio Ponzoni, Laura Galli, Giuseppe Consogno, Luca Gianotti, Claudio Fortis, Marco Braga and Oreste ­Gentilini and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Marco Foppoli

28 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Foppoli Italy 12 392 369 291 159 138 30 738
Erdwine Klinker Germany 13 396 1.0× 191 0.5× 169 0.6× 186 1.2× 145 1.1× 21 672
Shigeki Fujita Japan 13 359 0.9× 89 0.2× 194 0.7× 68 0.4× 308 2.2× 30 592
Nazan Özsan Türkiye 13 385 1.0× 95 0.3× 104 0.4× 133 0.8× 213 1.5× 46 646
Kirsten Herbert Australia 14 251 0.6× 146 0.4× 154 0.5× 128 0.8× 210 1.5× 26 684
Sung Sik Shin United States 15 338 0.9× 89 0.2× 128 0.4× 100 0.6× 208 1.5× 22 647
Marie‐Louise Geerts Belgium 13 1.3k 3.4× 548 1.5× 230 0.8× 184 1.2× 278 2.0× 18 1.7k
Chae H. Koo United States 13 300 0.8× 80 0.2× 157 0.5× 72 0.5× 188 1.4× 17 525
Marina Narbaitz Argentina 15 423 1.1× 75 0.2× 113 0.4× 126 0.8× 411 3.0× 55 663
Jun Odawara Japan 12 226 0.6× 231 0.6× 117 0.4× 29 0.2× 87 0.6× 32 555
Minoru Kojima Japan 14 354 0.9× 61 0.2× 176 0.6× 128 0.8× 318 2.3× 42 623

Countries citing papers authored by Marco Foppoli

Since Specialization
Citations

This map shows the geographic impact of Marco Foppoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Foppoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Foppoli more than expected).

Fields of papers citing papers by Marco Foppoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Foppoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Foppoli. The network helps show where Marco Foppoli may publish in the future.

Co-authorship network of co-authors of Marco Foppoli

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Foppoli. A scholar is included among the top collaborators of Marco Foppoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Foppoli. Marco Foppoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ferreri, Andrés J.M., Piera Angelillo, Chiara Cattaneo, et al.. (2022). Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma. Blood Advances. 6(22). 5811–5820.
3.
Calimeri, Teresa, Sara Steffanoni, Marco Foppoli, Maurilio Ponzoni, & Andrés J.M. Ferreri. (2021). Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphoma. Expert Opinion on Therapeutic Targets. 25(9). 749–760. 1 indexed citations
4.
Foppoli, Marco, et al.. (2021). A minimal physiologically based pharmacokinetic model for high-dose methotrexate. Cancer Chemotherapy and Pharmacology. 88(4). 595–606. 4 indexed citations
5.
6.
Ferreri, Andrés J.M., Teresa Calimeri, Marianna Sassone, et al.. (2017). Prophylaxis with high‐dose methotrexate significantly reduces CNS dissemination in patients with diffuse large B‐cell lymphoma (DLBCL) and high‐risk CNS‐IPI score. Hematological Oncology. 35(S2). 198–198. 3 indexed citations
7.
Calimeri, Teresa, Marianna Sassone, Marco Foppoli, et al.. (2016). High-dose methotrexate (HD-MTX) as CNS prophylaxis significantly improves outcome in patients with high-risk diffuse large B-cell lymphoma (DLBCL). Annals of Oncology. 27. vi313–vi313. 2 indexed citations
8.
Montanaro, Claudia, Ferdinando Loiacono, Gabriele Fragasso, et al.. (2015). Primary Cardiac Lymphoma in an Immunocompetent 71-Year-Old Man. Texas Heart Institute Journal. 42(6). 561–564. 5 indexed citations
9.
10.
Foppoli, Marco & Andrés J.M. Ferreri. (2014). Gamma‐delta t‐cell lymphomas. European Journal Of Haematology. 94(3). 206–218. 52 indexed citations
11.
12.
13.
Ferreri, Andrés J.M., Giada Licata, Marco Foppoli, et al.. (2011). Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination. The Oncologist. 16(3). 336–341. 24 indexed citations
14.
Ponti, Giovanni, Maurilio Ponzoni, Andrés JM Ferreri, et al.. (2008). The impact of histopathologic diagnosis on the proper management of testis neoplasms. Nature Clinical Practice Oncology. 5(10). 619–622. 2 indexed citations
15.
Reni, Michele, Elena Mazza, Marco Foppoli, & Andrés J.M. Ferreri. (2007). Primary central nervous system lymphomas: Salvage treatment after failure to high-dose methotrexate. Cancer Letters. 258(2). 165–170. 25 indexed citations
16.
Ferreri, Andrés J.M., Stefania Dell’Oro, Daniela Capello, et al.. (2004). Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas. British Journal of Haematology. 126(5). 657–664. 72 indexed citations
17.
Ferreri, Andrés J.M., Stefania Dell’Oro, Michele Reni, et al.. (2003). Questions and answers in the management of primary central nervous system and ocular lymphomas.. PubMed. 88(9). 1063–8. 3 indexed citations
18.
Fortis, Claudio, Marco Foppoli, Luca Gianotti, et al.. (1996). Increased interleukin-10 serum levels in patients with solid tumours. Cancer Letters. 104(1). 1–5. 135 indexed citations
19.
Citterio, Giovanni, Gabriele Fragasso, Giuseppe Di Lucca, et al.. (1996). Isolated Left Ventricular Filling Abnormalities May Predict Interleukin-2-Induced Cardiovascular Toxicity. Journal of Immunotherapy. 19(2). 134–141. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erdwine Klinker Breakdown of academic impact, for papers by Shigeki Fujita Breakdown of academic impact, for papers by Nazan Özsan Breakdown of academic impact, for papers by Kirsten Herbert Breakdown of academic impact, for papers by Sung Sik Shin Breakdown of academic impact, for papers by Marie‐Louise Geerts Breakdown of academic impact, for papers by Chae H. Koo Breakdown of academic impact, for papers by Marina Narbaitz Breakdown of academic impact, for papers by Jun Odawara Breakdown of academic impact, for papers by Minoru Kojima
Rankless by CCL
2026